Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-23-007180

EVP R&D, Chief Medical Officer gave up 5,345 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 12,038 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-22 Exercise or conversion : show line 1 in the form +12,038 61,904 D
2023-02-22 Shares withheld for taxes : show line 2 in the form −5,345 $27.77 $148,431 56,559 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-22 Exercise or conversion : show line 3 in the form Restricted Stock Unit Award −12,038 24,076 D
2023-02-23 Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) +120,615 120,615 D
2023-02-23 Grant or award : show line 5 in the form Restricted Stock Unit Award +30,154 30,154 D
Loading xslF345X03/form4.xml…